
[Federal Register Volume 77, Number 244 (Wednesday, December 19, 2012)]
[Notices]
[Page 75223]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30665]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


Spencer Pharmaceutical Inc.; Order of Suspension of Trading

December 17, 2012.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Spencer Pharmaceutical Inc. (``Spencer'') because of questions 
regarding the accuracy of publicly disseminated information, 
concerning, among other things: (1) The company's current financial 
condition; and (2) statements made by Spencer in press releases 
concerning, among other things, an unsolicited buyout offer of Spencer 
by a foreign company.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of the 
above-listed company, and any equity securities of any entity 
purporting to succeed to this issuer, is suspended for the period from 
9:30 a.m. EST on Monday, December 17, 2012, through 11:59 p.m. EST on 
Monday, December 31, 2012.

    By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2012-30665 Filed 12-17-12; 11:15 am]
BILLING CODE 8011-01-P


